X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with SUVEN LIFE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs SUVEN LIFE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA SUVEN LIFE ELDER PHARMA/
SUVEN LIFE
 
P/E (TTM) x -0.2 19.2 - View Chart
P/BV x 0.1 3.6 2.8% View Chart
Dividend Yield % 0.0 1.1 -  

Financials

 ELDER PHARMA   SUVEN LIFE
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
SUVEN LIFE
Mar-16
ELDER PHARMA/
SUVEN LIFE
5-Yr Chart
Click to enlarge
High Rs380339 112.3%   
Low Rs188144 130.2%   
Sales per share (Unadj.) Rs491.239.2 1,251.6%  
Earnings per share (Unadj.) Rs-3.27.5 -42.6%  
Cash flow per share (Unadj.) Rs14.48.8 164.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.8 0.0%  
Book value per share (Unadj.) Rs376.549.0 768.4%  
Shares outstanding (eoy) m20.54127.28 16.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.66.2 9.4%   
Avg P/E ratio x-89.332.4 -275.8%  
P/CF ratio (eoy) x19.727.5 71.6%  
Price / Book Value ratio x0.84.9 15.3%  
Dividend payout %026.8 0.0%   
Avg Mkt Cap Rs m5,83330,732 19.0%   
No. of employees `000NA1.0 0.0%   
Total wages/salary Rs m2,179416 523.3%   
Avg. sales/employee Rs ThNM5,236.1-  
Avg. wages/employee Rs ThNM436.5-  
Avg. net profit/employee Rs ThNM995.5-  
INCOME DATA
Net Sales Rs m10,0894,995 202.0%  
Other income Rs m257194 132.6%   
Total revenues Rs m10,3465,189 199.4%   
Gross profit Rs m-7921,233 -64.2%  
Depreciation Rs m361167 216.1%   
Interest Rs m2,75654 5,085.4%   
Profit before tax Rs m-3,6531,205 -303.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m125255 49.1%   
Profit after tax Rs m-65950 -6.9%  
Gross profit margin %-7.824.7 -31.8%  
Effective tax rate %-3.421.2 -16.2%   
Net profit margin %-0.619.0 -3.4%  
BALANCE SHEET DATA
Current assets Rs m9,2404,986 185.3%   
Current liabilities Rs m9,9981,042 959.3%   
Net working cap to sales %-7.579.0 -9.5%  
Current ratio x0.94.8 19.3%  
Inventory Days Days4661 75.9%  
Debtors Days Days6039 153.2%  
Net fixed assets Rs m10,1243,126 323.9%   
Share capital Rs m206127 161.6%   
"Free" reserves Rs m5,5823,717 150.2%   
Net worth Rs m7,7346,236 124.0%   
Long term debt Rs m4,889432 1,130.9%   
Total assets Rs m22,8828,079 283.2%  
Interest coverage x-0.323.2 -1.4%   
Debt to equity ratio x0.60.1 912.0%  
Sales to assets ratio x0.40.6 71.3%   
Return on assets %11.812.4 94.6%  
Return on equity %-0.815.2 -5.5%  
Return on capital %22.318.9 118.2%  
Exports to sales %3.087.5 3.5%   
Imports to sales %0.412.2 3.5%   
Exports (fob) Rs m3074,371 7.0%   
Imports (cif) Rs m43611 7.1%   
Fx inflow Rs m3074,666 6.6%   
Fx outflow Rs m125942 13.3%   
Net fx Rs m1813,724 4.9%   
CASH FLOW
From Operations Rs m11,754922 1,274.8%  
From Investments Rs m-561-619 90.5%  
From Financial Activity Rs m-6,762-698 968.2%  
Net Cashflow Rs m4,432-396 -1,120.0%  

Share Holding

Indian Promoters % 39.6 63.4 62.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 16.8 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 36.5 98.9%  
Shareholders   16,479 37,287 44.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   BIOCON LTD  WOCKHARDT LTD.  AUROBINDO PHARMA  PLETHICO PHARMA  GLENMARK PHARMA  

Compare ELDER PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes Firm; Software & FMCG Stocks Gain(Closing)

Indian share markets finished the trading session well above the dotted line, snapping a three-day falling streak amid firm Asian markets.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Follow India's Super Investors to Make Big Money in the Market Crash(The 5 Minute Wrapup)

Feb 8, 2018

Has the sell-off in the markets left India's super investors unduly worried?

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

Rising Dominance of Mutual Funds(Chart Of The Day)

Feb 8, 2018

Domestic money flow into Indian equities surpassed foreign fund flows in the recent years. But will it continue in volatile market?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - SANOFI INDIA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS